Dr. Anton Galich

Dr. Anton Galich
Dr. Galich joined KCUC after spending 10 years at Saint Francis Hospital in Tulsa, Oklahoma where he was the Chief of Urology during his final 2 years. Dr. Galich started his medical career at National Medical University in Kyiv, Ukraine which he finished Summa Cum Laude. He finished his Clinical clerkships at the University of Rochester, Rochester, NY. Dr. Galich completed his general surgery training at Saint Agnes Hospital in Baltimore, MD and his urology residency at the University of Nebraska Medical Center, Omaha, NE. He was actively engaged in research related to minimally invasive surgery and prostate cancer biochemistry while at the University Of Nebraska Medical Center, co-authoring several articles and presenting at regional and national meetings. Dr. Galich practices all aspects of general urology including kidney stone disease, incontinence, sexual dysfunction, prostate problems and urologic cancers with particular interest in minimally invasive surgery. Dr. Galich completed over 390 robotic procedures including such advanced surgeries as robotic radical cystectomies. He is also trained to perform the latest minimally invasive procedures including UroLift for BPH, InterStim neuromodulation for overactive bladder, magnetic resonance fusion prostate biopsies for prostate cancer diagnosis, and penile prosthesis for erectile dysfunction. Dr. Galich is licensed in both Missouri and Kansas. He is a diplomat of the American Board of Urology, and a member of the American Urologic Association. He is a former participant in national level competitions in track and field.
Medical School:

National Medical University, Kiev, Ukraine

Residency:

University of Nebraska College of Medicine

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only